Improved clinical outcome using transarterial chemoembolization combined with radiofrequency ablation for patients in Barcelona clinic liver cancer stage A or B hepatocellular carcinoma regardless of tumor size: results of a single-center retrospective case control study

Improved clinical outcome using transarterial chemoembolization combined with radiofrequency ablation for patients in Barcelona clinic liver cancer stage A or B hepatocellular carcinoma regardless of tumor size: results of a single-center retrospective case control study

Abstract Background To determine the safety and efficacy of transarterial chemoembolization (TACE) combined with radiofrequency ablation (hereafter, TACE-RFA) in treating Barcelona Clinic Liver Cancer (BCLC) Stage A or B (hereafter, BCLC A/B) hepatocellular carcinoma (HCC) patients, and to explore t...

Full description

Bibliographic Details
Main Authors: Yanqiao Ren, Yanyan Cao, Hong Ma, Xuefeng Kan, Chen Zhou, Jiacheng Liu, Qin Shi, Gansheng Feng, Bin Xiong, Chuansheng Zheng
Format: Article
Language:English
Published: BMC 2019-10-01
Series:BMC Cancer
Subjects:
Chemoembolization
Therapeutic
Radiofrequency ablation
Hepatocellular carcinoma
Online Access:http://link.springer.com/article/10.1186/s12885-019-6237-5

Internet

http://link.springer.com/article/10.1186/s12885-019-6237-5

Similar Items